Higher survival rates among younger patients after pediatric intensive care unit cardiac arrests

Peter A Meaney1, Vinay M Nadkarni, E Francis Cook

  • 1Department of Critical Care Medicine, 7th Floor, Room 7c03, Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA. Meaney@email.chop.edu

Pediatrics
|December 5, 2006
PubMed

Insights

Infants and newborns show significantly better survival rates after pediatric intensive care unit (ICU) cardiac arrests compared to older children. This age-dependent survival highlights critical differences in pediatric resuscitation outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Resuscitation science
  • Pediatric emergency medicine

Background:

  • Age is a known factor in adult cardiac arrest outcomes, but its role in pediatric cardiac arrests is less understood, except in premature infants.
  • Infants' increased chest wall compliance may facilitate more effective blood flow during chest compressions compared to older children and adults.
  • Previous research has not definitively established age as a key determinant of survival in pediatric cardiac arrest scenarios.

Purpose of the Study:

  • To investigate the association between age and survival outcomes in pediatric patients experiencing cardiac arrest within an intensive care unit (ICU) setting.
  • To determine if infants and newborns have different survival rates compared to older children following ICU cardiac arrest.
  • To analyze age-specific survival data from a large national registry of pediatric cardiopulmonary resuscitation.

Main Methods:

  • Evaluation of 464 pediatric ICU cardiac arrests from the National Registry of Cardiopulmonary Resuscitation (2000-2002), excluding neonatal intensive care unit (NICU) arrests.
  • Categorization of patient age into four groups: newborn (<1 month), infant (1 month to <1 year), younger child (1 year to <8 years), and older child (8 years to <21 years).
  • Application of multivariable logistic regression to analyze the relationship between age categories and survival to hospital discharge, controlling for potential confounders.

Main Results:

  • Overall survival to hospital discharge was 22%, with variations across age groups: newborns (27%), infants (36%), younger children (19%), and older children (16%).
  • Newborns and infants demonstrated significantly higher odds of survival compared to older children (double and triple odds, respectively).
  • After adjusting for confounding variables, newborns showed nearly a fivefold increase in survival odds, while infants maintained a significant survival advantage over older children.

Conclusions:

  • Survival rates following pediatric ICU cardiac arrest are significantly dependent on patient age.
  • Newborns and infants exhibit superior survival rates compared to older children, even after accounting for various confounding factors.
  • These findings underscore the importance of age as a critical prognostic indicator in pediatric cardiac arrest management within intensive care settings.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...